Stroke & Vascular

Featured Article
Ticagrelor, Aspirin, or both?
True or False: Endovascular therapy after stroke improved quality of life outcomes for patients.
Quality of life outcomes improved for patients treated with endovascular therapy 6 to 16 hours after stroke versus standard therapy alone, according to secondary analysis of the DEFUSE 3 randomized clinical trial.
For which events is primary stroke prevention indicated? Test your knowledge in our pop quiz.
In a multicentric retrospective cohort study, researchers derived and externally validated a risk score to predict neurological deterioration of ischemic origin among patients with minor stroke and large vessel occlusion treated with intravenous thrombolysis.
A recent CDC report indicates that one-third of US adults do not have the recommended knowledge of stroke symptoms. Do you find that your patients often have the recommended knowledge of the signs of stroke? Share your experience in our latest poll.
In the THALES randomized clinical trial, investigators compared the effects of aspirin plus ticagrelor vs aspirin alone in reducing disabling recurrent stroke among patients with minor ischemic stroke or transient ischemic attack.
A new CDC report indicates that a significant proportion of US adults do not have the recommended knowledge of stroke symptoms, highlighting significant disparities in this area.
The authors of a new study published in Stroke investigated whether apical lung assessment on computed tomography angiography, which is performed among patients with acute ischemic stroke, could also identify possible COVID-19 among these patients.
In a randomized study, researchers investigated whether using a stroke alarm clock that demands active feedback from stroke physicians could help accelerate acute stroke care.
In a recent analysis, researchers aimed to compare outcomes associated with intensive vs standard systolic blood pressure reduction among patients with intracerebral hemorrhage with excessively high initial systolic blood pressure.